Journal of Neuro-Oncology

, Volume 65, Issue 3, pp 261–267

Clinical Gene Therapy for Brain Tumors. Liposomal Delivery of Anticancer Molecule to Glioma

  • Jun Yoshida
  • Masaaki Mizuno

DOI: 10.1023/B:NEON.0000003655.03671.fa

Cite this article as:
Yoshida, J. & Mizuno, M. J Neurooncol (2003) 65: 261. doi:10.1023/B:NEON.0000003655.03671.fa


Liposomes are one of the most promising delivery systems for genes, proteins, and other biological molecules and they are expected to become a new therapeutic tool for the treatment of brain tumors, especially malignant gliomas. Until now, transfer of anticancer molecules using liposomes has been studied by a lot of investigators and it has been found to induce regression of experimental gliomas, resulting in establishing some original and effective therapies. Gene therapy using cationic liposomes is also one of them. Here we introduce the advanced medicine for brain tumors using liposomes containing some anticancer molecules (for example, gene, antibody, antisense, or magnetite), based on our basic and clinical research.

brain tumorgene therapyinterferonliposome

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Jun Yoshida
    • 1
  • Masaaki Mizuno
    • 2
  1. 1.Department of NeurosurgeryNagoya University Graduate School of MedicineNagoyaJapan
  2. 2.Department of Molecular NeurosurgeryNagoya University Graduate School of MedicineNagoyaJapan